Docstoc

Xtremepicks Reports on Sunpeaks Ventures, Inc (SNPK)

Document Sample
Xtremepicks Reports on Sunpeaks Ventures, Inc (SNPK) Powered By Docstoc
					Xtremepicks Reports on Sunpeaks Ventures, Inc (SNPK)

SNPK traded over 200 million shares over the last 2 trading session
making it the highest traded stock on the OTC last week. Definitely
giving liquidity in this day traders market.

Silver Spring, MD, March 12, 2012 -- Sunpeaks Ventures, Inc. (OTCBB:
SNPK) (PINKSHEETS: SNPK) (the “Company” or “Sunpeaks Ventures”) and its
wholly owned subsidiary Healthcare Distribution Specialist, LLC (“HDS”)
is pleased to announce that since July 2011 Dakota Drug Inc. has been a
wholesale distributor of Clotamin®. Clotamin® is the world’s first
specialized OTC multivitamin product designed exclusively for use by
patients on Warfarin® and other anticoagulants (blood thinners). Founded
in 1948, Dakota Drug is an independent full service healthcare
distributor dedicated to providing service to pharmacies, retail drug
stores and hospitals.

“As we have indicated, the Sunpeaks team is systematically targeting
every essential wholesaler with the goal of reaching each small and
medium sized pharmacy across the United States,” stated Mackie A. Barch,
CEO of Sunpeaks. “It is through these well-known distributors and
pharmacies that our brand will continue to grab more market presence.
Additional wholesale distribution agreements are expected to be completed
in the near future that will expand Clotamin’s availability nationwide.”

Clotamin is now available in North Dakota, South Dakota, Montana,
Wyoming, Illinois, Nebraska, Iowa, Wisconsin and Minnesota.

About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare
Distribution Specialists, LLC (“HDS”), is a nationally focused, value-
added distributor of specialty drugs and over-the-counter (“OTC”) branded
multivitamins to the healthcare provider market. HDS also owns and
markets Clotamin®, a specialized over-the-counter multivitamin product
designed exclusively for use by patients also on Warfarin®, a popular
blood thinner that has a long list of known adverse drug and food
interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com

Safe Harbor Statement
Information in this document constitute forward-looking statements or
statements which may be deemed or construed to be forward-looking
statements within the meaning of the Private Securities Litigation Reform
Act of 1995. The words “forecast”, “anticipate”, “estimate”, “project”,
“intend”, “expect”, “should”, “believe”, and similar expressions are
intended to identify forward-looking statements. These forward-looking
statements involve, and are subject to known and unknown risks,
uncertainties and other factors which could cause Sunpeaks Ventures’
actual results, performance (financial or operating) or achievements to
differ from the future results, performance (financial or operating) or
achievements expressed or implied by such forward-looking statements. The
risks, uncertainties and other factors are more fully discussed in
Sunpeaks Ventures’ filings with the U.S. Securities and Exchange
Commission. All forward-looking statements attributable to Sunpeaks
Ventures herein are expressly qualified in their entirety by the above-
mentioned cautionary statement. Sunpeaks Ventures disclaims any
obligation to update forward-looking statements contained in this
estimate, except as may be required by law.

About Xtremepicks.com
Xtremepicks.com team of excellence strives to find undervalued, good
momentum stock plays. Xtremepicks.com provide market awareness services
for small to mid-cap stocks with daily and special newsletters to keep
you informed of the latest movers.

Xtremepicks.com penny stock newsletter is your trading connection and
remember to always do your own research, use stop loss orders to protect
yourself, and book your profits when in a position to do so.

Xtremepicks.com penny stock newsletter profiles are not a solicitation or
recommendation to buy, sell or hold securities and is not offering
securities for sale. Verify all claims and do your own due diligence. .
Xtremepicks received no compensation for SNPK and may be buyers in the
open market. An offer to buy or sell can be made only with accompanying
disclosure documents and only in the states and provinces for which they
are approved.

Contact:
Max Gordon
Xtremepicks.com
7 New Road
Belize City, Belize
6479227508
contact@directglobalmedia.com
http://www.xtremepicks.com/

reports, sunpeaks ventures, trade, traders market, healthcare, service,
pharmacy

				
DOCUMENT INFO
Shared By:
Stats:
views:12
posted:3/12/2012
language:
pages:2
Description: SNPK traded over 200 million shares over the last 2 trading session making it the highest traded stock on the OTC last week. Definitely giving liquidity in this day traders market.